SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600132-19-000105
Filing Date
2019-08-08
Accepted
2019-08-08 08:31:09
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q blph06301910q.htm 10-Q 917886
2 EXHIBIT 31.1 blph06301910qexhibit311.htm EX-31.1 9909
3 EXHIBIT 31.2 blph06301910qexhibit312.htm EX-31.2 9898
4 EXHIBIT 32 blph06301910qexhibit32.htm EX-32 10896
  Complete submission text file 0001600132-19-000105.txt   4248876

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blph-20190630.xml EX-101.INS 792067
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blph-20190630.xsd EX-101.SCH 33882
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blph-20190630_cal.xml EX-101.CAL 49452
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blph-20190630_def.xml EX-101.DEF 144305
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blph-20190630_lab.xml EX-101.LAB 469217
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blph-20190630_pre.xml EX-101.PRE 264429
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36845 | Film No.: 191007594
SIC: 2834 Pharmaceutical Preparations